List of works - Kazunori Fujitaka

A Case of Central Diabetes Insipidus That Was Caused by Pituitary Metastasis of Lung Adenocarcinoma and Was Controlled by Radiation Therapy

scientific article published in June 2017

A case of micronodular pneumocyte hyperplasia diagnosed through lung biopsy using thoracoscopy

scientific article

A case of pulmonary asbestosis presenting with temporal arteritis involving multiple medium-sized vessels

scientific article

A case of pulmonary pleomorphic carcinoma accompanied by pulmonary hypertrophic osteoarthropathy

scientific article published on 01 October 2011

A case with life-threatening secondary sclerosing cholangitis caused by nivolumab

scientific article published on 16 November 2020

A pharmacokinetics study of edoxaban in NSCLC patients harboring an EGFR mutation combined with venous thromboembolism ⬇️

scholarly article

AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis.

scientific article published on 14 February 2017

AGER rs2070600 polymorphism elevates neutrophil-lymphocyte ratio and mortality in metastatic lung adenocarcinoma.

scientific article published on 10 October 2017

Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis

scientific article

Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer

scientific article published on 17 September 2019

Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma

scientific article published on 30 September 2020

Alternate-day administration of S-1 for elderly patients with advanced non-small-cell lung carcinoma: A prospective feasibility study

scientific article published on 24 August 2018

Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma

scientific article published on 24 May 2018

Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1

scientific article published on 30 October 2018

Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity

scientific article published on 23 August 2021

Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor-Induced Interstitial Lung Disease Among Patients With Nonlung Cancers

scientific article published on 02 November 2020

Baseline High-Resolution CT Findings Predict Acute Exacerbation of Idiopathic Pulmonary Fibrosis: German and Japanese Cohort Study

scientific article published on 24 November 2019

Bevacizumab with Single-agent Chemotherapy in Previously Treated Non-squamous Non-small-cell Lung Cancer: Phase II Study

scientific article published on 01 September 2018

C-C Motif Chemokine Ligand 15 May Be a Useful Biomarker for Predicting the Prognosis of Patients with Chronic Hypersensitivity Pneumonitis

scientific article published on 15 August 2019

Cerebral embolism during edoxaban administration for venous thromboembolism in a patient with lung adenocarcinoma: A case report

scientific article published on 01 March 2019

Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease ⬇️

scientific article published on July 26, 2011

Chemotherapy-associated Acute Exacerbation of Interstitial Lung Disease Shortens Survival Especially in Small Cell Lung Cancer

scientific article published on 01 October 2019

Chronic Intestinal Pseudo-obstruction and Orthostatic Hypotension Associated with Small Cell Lung Cancer that Improved with Tumor Reduction after Chemoradiotherapy

scientific article published on 6 September 2017

Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non-small cell lung cancer

scientific article published on 26 October 2020

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis: A Case Report

scientific article published on 23 June 2020

Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.

scientific article published on 17 May 2016

Comparison of anti-aminoacyl-tRNA synthetase antibody-related and idiopathic non-specific interstitial pneumonia

scientific article published on 01 May 2019

Concomitant emphysema might increase the false-negative rate of urinary antigen tests in patients with pneumococcal pneumonia: results from a retrospective study

scientific article published on 04 November 2020

Correlations of forced oscillometric bronchodilator response with airway inflammation and disease duration in asthma

scientific article published on 28 August 2020

Effect of increasing respiratory rate on airway resistance and reactance in COPD patients

scientific article published on 23 September 2014

Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy ⬇️

scientific article published on January 28, 2011

Extent of pulmonary fibrosis on high-resolution computed tomography is a prognostic factor in patients with pleuroparenchymal fibroelastosis

scientific article published on 03 August 2020

FAM13A polymorphism as a prognostic factor in patients with idiopathic pulmonary fibrosis

scientific article published on 22 December 2016

Feasibility and Safety of CT-guided Intrathoracic and Bone Re-biopsy for Non-small Cell Lung Cancer.

scientific article

Genetic ablation of the Bach1 gene reduces hyperoxic lung injury in mice: role of IL-6.

scientific article published on 29 January 2009

High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery

scientific article published on 01 February 2019

Histological Quantification of Gene Silencing by Intratracheal Administration of Dry Powdered Small-Interfering RNA/Chitosan Complexes in the Murine Lung

scientific article

Impact of HER2 expression on EGFR-TKI treatment outcomes in lung tumors harboring EGFR mutations: A HER2-CS study subset analysis

scientific article published on 01 October 2020

Inhibition of PAI-1 Limits Tumor Angiogenesis Regardless of Angiogenic Stimuli in Malignant Pleural Mesothelioma.

scientific article published on 13 April 2016

Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts

scientific article published on 07 February 2019

Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts

scientific article published on 9 February 2016

Interferon (Alpha, Beta and Omega) Receptor 2 Is a Prognostic Biomarker for Lung Cancer ⬇️

scientific article published on January 12, 2012

Intra-airway administration of small interfering RNA targeting plasminogen activator inhibitor-1 attenuates allergic asthma in mice ⬇️

scientific article published on September 16, 2011

Intratracheal Administration of siRNA Dry Powder Targeting Vascular Endothelial Growth Factor Inhibits Lung Tumor Growth in Mice

scientific article published on 17 July 2018

Investigating the relationship between serum thrombopoietin kinetics and the platelet-sparing effect: A clinical pharmacological evaluation of combined paclitaxel and carboplatin in patients with non-small cell lung cancer

scientific article

Long-term pulmonary complications of chemical weapons exposure in former poison gas factory workers

scientific article

MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model

scientific article published on 29 May 2015

MUC1 in lung adenocarcinoma: cross-sectional genetic and serological study

scientific article

Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study

Neutropenic enterocolitis in lung cancer: a report of two cases and a review of the literature

scientific article

Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinoma

scientific article published on 2 March 2018

Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with Polyangiitis

scientific article published on 10 July 2019

Novel prospective umbrella-type lung cancer registry study for clarifying clinical practice patterns: CS-Lung-003 study protocol

Performance Status Is a Risk Factor for Depression before the Diagnosis of Lung Cancer Patients

scientific article published on 18 December 2018

Pharmacokinetics of edoxaban in EGFR-mutated non-small cell lung cancer patients with venous thromboembolism

scientific article published on 30 December 2020

Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol

scientific article published on 01 November 2018

Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer

scientific article

Plasminogen activator inhibitor-1 serves an important role in radiation-induced pulmonary fibrosis

Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer

scientific article published on 24 June 2019

Pulmonary arteriovenous malformation exhibiting recanalization >10 years after coil embolization: Two case reports

scientific article published on 01 January 2020

Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis

scientific article published on 11 June 2020

Regression of a primary pulmonary adenocarcinoma after zoledronic acid monotherapy

scientific article published on 01 March 2011

SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis

scientific article published on 29 August 2013

Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: A retrospective cohort study

scientific article published on 01 December 2018

Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease

scientific article published on 28 August 2020

Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis

scientific article published on 03 July 2019

Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice

scientific article published on 2 October 2008

Suplatast tosilate protects the lung against hyperoxic lung injury by scavenging hydroxyl radicals.

scientific article

Suplatast tosilate reduces radiation-induced lung injury in mice through suppression of oxidative stress

scientific article published on 28 March 2019

Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis

scientific article published on April 2010

The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer

scientific article published on 15 November 2017

Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer

scientific article published on 01 March 2020

Trichosporon antibodies (corrected of antigen) and HLA-antigen in summer-type hypersensitivity pneumonitis in a family

scientific article

Use of proton pump inhibitors is associated with increased mortality due to nosocomial pneumonia in bedridden patients receiving tube feeding

scientific article published on 22 May 2018

Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.

scientific article published in June 2008

Usefulness of the modified lavage technique of Bingisser and KL-6 monitoring in a patient with pulmonary alveolar proteinosis

scientific article published on 01 May 2002

Validation of the limited-sampling models for carboplatin AUC in combination chemotherapy with taxanes.

scientific article

[Case report: A case of Hodgkin lymphoma required a differential diagnosis from sarcoidosis due to elevated serum level of angiotensin converting enzyme (ACE)]

scientific article published on 01 May 2012

List of works by Kazunori Fujitaka

A Case of Central Diabetes Insipidus That Was Caused by Pituitary Metastasis of Lung Adenocarcinoma and Was Controlled by Radiation Therapy

A case of micronodular pneumocyte hyperplasia diagnosed through lung biopsy using thoracoscopy

A case of pulmonary asbestosis presenting with temporal arteritis involving multiple medium-sized vessels

A case of pulmonary pleomorphic carcinoma accompanied by pulmonary hypertrophic osteoarthropathy

A case with life-threatening secondary sclerosing cholangitis caused by nivolumab

A pharmacokinetics study of edoxaban in NSCLC patients harboring an EGFR mutation combined with venous thromboembolism ⬇️

AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis.

AGER rs2070600 polymorphism elevates neutrophil-lymphocyte ratio and mortality in metastatic lung adenocarcinoma.

Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis

Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer

Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma

Alternate-day administration of S-1 for elderly patients with advanced non-small-cell lung carcinoma: A prospective feasibility study

Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma

Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1

Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity

Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor-Induced Interstitial Lung Disease Among Patients With Nonlung Cancers

Baseline High-Resolution CT Findings Predict Acute Exacerbation of Idiopathic Pulmonary Fibrosis: German and Japanese Cohort Study

Bevacizumab with Single-agent Chemotherapy in Previously Treated Non-squamous Non-small-cell Lung Cancer: Phase II Study

C-C Motif Chemokine Ligand 15 May Be a Useful Biomarker for Predicting the Prognosis of Patients with Chronic Hypersensitivity Pneumonitis

Cerebral embolism during edoxaban administration for venous thromboembolism in a patient with lung adenocarcinoma: A case report

Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease ⬇️

Chemotherapy-associated Acute Exacerbation of Interstitial Lung Disease Shortens Survival Especially in Small Cell Lung Cancer

Chronic Intestinal Pseudo-obstruction and Orthostatic Hypotension Associated with Small Cell Lung Cancer that Improved with Tumor Reduction after Chemoradiotherapy

Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non-small cell lung cancer

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis: A Case Report

Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.

Comparison of anti-aminoacyl-tRNA synthetase antibody-related and idiopathic non-specific interstitial pneumonia

Concomitant emphysema might increase the false-negative rate of urinary antigen tests in patients with pneumococcal pneumonia: results from a retrospective study

Correlations of forced oscillometric bronchodilator response with airway inflammation and disease duration in asthma

Effect of increasing respiratory rate on airway resistance and reactance in COPD patients

Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy ⬇️

Extent of pulmonary fibrosis on high-resolution computed tomography is a prognostic factor in patients with pleuroparenchymal fibroelastosis

FAM13A polymorphism as a prognostic factor in patients with idiopathic pulmonary fibrosis

Feasibility and Safety of CT-guided Intrathoracic and Bone Re-biopsy for Non-small Cell Lung Cancer.

Genetic ablation of the Bach1 gene reduces hyperoxic lung injury in mice: role of IL-6.

High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery

Histological Quantification of Gene Silencing by Intratracheal Administration of Dry Powdered Small-Interfering RNA/Chitosan Complexes in the Murine Lung

Impact of HER2 expression on EGFR-TKI treatment outcomes in lung tumors harboring EGFR mutations: A HER2-CS study subset analysis

Inhibition of PAI-1 Limits Tumor Angiogenesis Regardless of Angiogenic Stimuli in Malignant Pleural Mesothelioma.

Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts

Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts

Interferon (Alpha, Beta and Omega) Receptor 2 Is a Prognostic Biomarker for Lung Cancer ⬇️

Intra-airway administration of small interfering RNA targeting plasminogen activator inhibitor-1 attenuates allergic asthma in mice ⬇️

Intratracheal Administration of siRNA Dry Powder Targeting Vascular Endothelial Growth Factor Inhibits Lung Tumor Growth in Mice

Investigating the relationship between serum thrombopoietin kinetics and the platelet-sparing effect: A clinical pharmacological evaluation of combined paclitaxel and carboplatin in patients with non-small cell lung cancer

Long-term pulmonary complications of chemical weapons exposure in former poison gas factory workers

MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model

MUC1 in lung adenocarcinoma: cross-sectional genetic and serological study

Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study

Neutropenic enterocolitis in lung cancer: a report of two cases and a review of the literature

Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinoma

Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with Polyangiitis

Novel prospective umbrella-type lung cancer registry study for clarifying clinical practice patterns: CS-Lung-003 study protocol

Performance Status Is a Risk Factor for Depression before the Diagnosis of Lung Cancer Patients

Pharmacokinetics of edoxaban in EGFR-mutated non-small cell lung cancer patients with venous thromboembolism

Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol

Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer

Plasminogen activator inhibitor-1 serves an important role in radiation-induced pulmonary fibrosis

Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer

Pulmonary arteriovenous malformation exhibiting recanalization >10 years after coil embolization: Two case reports

Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis

Regression of a primary pulmonary adenocarcinoma after zoledronic acid monotherapy

SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis

Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: A retrospective cohort study

Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease

Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis

Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice

Suplatast tosilate protects the lung against hyperoxic lung injury by scavenging hydroxyl radicals.

Suplatast tosilate reduces radiation-induced lung injury in mice through suppression of oxidative stress

Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis

The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer

Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer

Trichosporon antibodies (corrected of antigen) and HLA-antigen in summer-type hypersensitivity pneumonitis in a family

Use of proton pump inhibitors is associated with increased mortality due to nosocomial pneumonia in bedridden patients receiving tube feeding

Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.

Usefulness of the modified lavage technique of Bingisser and KL-6 monitoring in a patient with pulmonary alveolar proteinosis

Validation of the limited-sampling models for carboplatin AUC in combination chemotherapy with taxanes.

[Case report: A case of Hodgkin lymphoma required a differential diagnosis from sarcoidosis due to elevated serum level of angiotensin converting enzyme (ACE)]